vs

Side-by-side financial comparison of CME Group (CME) and MATTEL INC (MAT). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $862.2M, roughly 2.2× MATTEL INC). MATTEL INC runs the higher net margin — 7.1% vs 0.1%, a 7.0% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 4.3%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -10.6%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Mattel Films was the film production division of American toy and entertainment company Mattel that operated from September 6, 2018 to June 2, 2025. It succeeded Mattel Playground Productions, which was formed on October 16, 2013 as part of Mattel Global Brands, a unified media structural and strategy unit, as itself the successor to Mattel Entertainment and Mattel Studios, Mattel's prior entertainment brands/banners.

CME vs MAT — Head-to-Head

Bigger by revenue
CME
CME
2.2× larger
CME
$1.9B
$862.2M
MAT
Growing faster (revenue YoY)
CME
CME
+10.2% gap
CME
14.5%
4.3%
MAT
Higher net margin
MAT
MAT
7.0% more per $
MAT
7.1%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-10.6%
MAT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
MAT
MAT
Revenue
$1.9B
$862.2M
Net Profit
$1.2M
$61.0M
Gross Margin
44.9%
Operating Margin
0.1%
Net Margin
0.1%
7.1%
Revenue YoY
14.5%
4.3%
Net Profit YoY
20.7%
251.4%
EPS (diluted)
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
MAT
MAT
Q1 26
$1.9B
$862.2M
Q4 25
$1.6B
$1.8B
Q3 25
$1.5B
$1.7B
Q2 25
$1.7B
$1.0B
Q1 25
$1.6B
$826.6M
Q4 24
$1.5B
$1.6B
Q3 24
$1.6B
$1.8B
Q2 24
$1.5B
$1.1B
Net Profit
CME
CME
MAT
MAT
Q1 26
$1.2M
$61.0M
Q4 25
$1.2B
$106.2M
Q3 25
$908.0M
$278.4M
Q2 25
$1.0B
$53.4M
Q1 25
$956.2M
$-40.3M
Q4 24
$874.6M
$140.9M
Q3 24
$912.8M
$372.4M
Q2 24
$883.2M
$56.9M
Gross Margin
CME
CME
MAT
MAT
Q1 26
44.9%
Q4 25
45.9%
Q3 25
50.0%
Q2 25
50.9%
Q1 25
49.4%
Q4 24
50.7%
Q3 24
53.1%
Q2 24
49.2%
Operating Margin
CME
CME
MAT
MAT
Q1 26
0.1%
Q4 25
61.8%
8.0%
Q3 25
63.3%
21.9%
Q2 25
66.7%
7.7%
Q1 25
67.5%
-6.4%
Q4 24
62.1%
9.6%
Q3 24
64.6%
26.5%
Q2 24
65.3%
7.7%
Net Margin
CME
CME
MAT
MAT
Q1 26
0.1%
7.1%
Q4 25
71.7%
6.0%
Q3 25
59.1%
16.0%
Q2 25
60.6%
5.2%
Q1 25
58.2%
-4.9%
Q4 24
57.3%
8.6%
Q3 24
57.6%
20.2%
Q2 24
57.6%
5.3%
EPS (diluted)
CME
CME
MAT
MAT
Q1 26
$0.20
Q4 25
$3.24
$0.32
Q3 25
$2.49
$0.88
Q2 25
$2.81
$0.16
Q1 25
$2.62
$-0.12
Q4 24
$2.40
$0.40
Q3 24
$2.50
$1.09
Q2 24
$2.42
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
MAT
MAT
Cash + ST InvestmentsLiquidity on hand
$2.4B
$866.0M
Total DebtLower is stronger
$3.4B
$2.3B
Stockholders' EquityBook value
$2.1B
Total Assets
$202.0B
$6.3B
Debt / EquityLower = less leverage
1.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
MAT
MAT
Q1 26
$2.4B
$866.0M
Q4 25
$4.5B
$1.2B
Q3 25
$2.6B
$691.9M
Q2 25
$2.1B
$870.5M
Q1 25
$1.5B
$1.2B
Q4 24
$3.0B
$1.4B
Q3 24
$2.4B
$723.5M
Q2 24
$1.9B
$722.4M
Total Debt
CME
CME
MAT
MAT
Q1 26
$3.4B
$2.3B
Q4 25
$2.3B
Q3 25
$2.3B
Q2 25
$2.3B
Q1 25
$2.3B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.3B
Stockholders' Equity
CME
CME
MAT
MAT
Q1 26
$2.1B
Q4 25
$28.7B
$2.2B
Q3 25
$28.2B
$2.3B
Q2 25
$27.7B
$2.2B
Q1 25
$27.0B
$2.1B
Q4 24
$26.5B
$2.3B
Q3 24
$28.2B
$2.3B
Q2 24
$27.6B
$2.0B
Total Assets
CME
CME
MAT
MAT
Q1 26
$202.0B
$6.3B
Q4 25
$198.4B
$6.6B
Q3 25
$187.1B
$6.6B
Q2 25
$179.9B
$6.2B
Q1 25
$157.8B
$6.2B
Q4 24
$137.4B
$6.5B
Q3 24
$137.8B
$6.5B
Q2 24
$123.4B
$5.9B
Debt / Equity
CME
CME
MAT
MAT
Q1 26
1.11×
Q4 25
1.04×
Q3 25
1.03×
Q2 25
1.08×
Q1 25
1.10×
Q4 24
1.03×
Q3 24
1.01×
Q2 24
1.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
MAT
MAT
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-88.1M
FCF MarginFCF / Revenue
-10.2%
Capex IntensityCapex / Revenue
7.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
MAT
MAT
Q1 26
Q4 25
$1.1B
$796.6M
Q3 25
$968.1M
$72.0M
Q2 25
$1.1B
$-300.1M
Q1 25
$1.1B
$24.8M
Q4 24
$1.0B
$862.1M
Q3 24
$1.0B
$155.8M
Q2 24
$776.9M
$-252.9M
Free Cash Flow
CME
CME
MAT
MAT
Q1 26
$-88.1M
Q4 25
$1.1B
Q3 25
$949.7M
Q2 25
$1.0B
Q1 25
$1.1B
Q4 24
$991.7M
Q3 24
$973.2M
Q2 24
$758.7M
FCF Margin
CME
CME
MAT
MAT
Q1 26
-10.2%
Q4 25
66.8%
Q3 25
61.8%
Q2 25
61.5%
Q1 25
67.1%
Q4 24
65.0%
Q3 24
61.4%
Q2 24
49.5%
Capex Intensity
CME
CME
MAT
MAT
Q1 26
7.6%
Q4 25
2.0%
Q3 25
1.2%
Q2 25
1.1%
Q1 25
0.9%
Q4 24
1.7%
Q3 24
1.9%
Q2 24
1.2%
Cash Conversion
CME
CME
MAT
MAT
Q1 26
Q4 25
0.96×
7.50×
Q3 25
1.07×
0.26×
Q2 25
1.03×
-5.62×
Q1 25
1.17×
Q4 24
1.16×
6.12×
Q3 24
1.10×
0.42×
Q2 24
0.88×
-4.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons